Cure Msd
Non Profit Organization Management, 2112 Bienville Blvd., Biloxi, Mississippi, 39564, United States, 1-10 Employees
Phone Number: +12*********
Who is CUREMSD
Our mission is simple, yet powerful: To cure Multiple Sulfatase Deficiency. Multiple Sulfatase Deficiency (MSD) ia a rare genetic, progressive, neurodegenerative disease caused by the bui...
Read More
- Headquarters: 2112 Bienville Blvd., Biloxi, Mississippi, 39564, United States
- Date Founded: 2016
- Employees: 1-10
- Revenue: $1 Million to $5 Million
- Active Tech Stack: See technologies
Industry: Non Profit Organization Management
SIC Code: 8641
CureMSD Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding CureMSD
Answer: CureMSD's headquarters are located at 2112 Bienville Blvd., Biloxi, Mississippi, 39564, United States
Answer: CureMSD's phone number is +12*********
Answer: CureMSD's official website is https://curemsd.org
Answer: CureMSD's revenue is $1 Million to $5 Million
Answer: CureMSD's SIC: 8641
Answer: CureMSD has 1-10 employees
Answer: CureMSD is in Non Profit Organization Management
Answer: CureMSD contact info: Phone number: +12********* Website: https://curemsd.org
Answer: Our mission is simple, yet powerful: To cure Multiple Sulfatase Deficiency. Multiple Sulfatase Deficiency (MSD) ia a rare genetic, progressive, neurodegenerative disease caused by the build up of cellular waste throughout the body leading to neurologic regression and multisystemic symptoms. Children with MSD rarely survive past their 13th birthday. Currently there is no treatment or cure available for MSD; however, there is hope. Various mutations of the SUMF1 gene are known to be the cause of MSD, and the knowledge of these specific gene mutations allows researchers and doctors to move forward and find a treatment and cure. Gene therapy could help slow the progression of the disease, and possibly deliver a cure. The United MSD Foundation is currently working with partner organizations, researchers, and doctors from all over the world to fund a first-in-human gene therapy clinical trial. Additional initiatives include continuing to identify patients worldwide, the development of a patient registry and biobank, and advocating for newborn screening across the United States.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month